Further supporting its multifaceted role, recent evidence also points toward an intriguing interaction between ALKBH5 and NEAT1 in colorectal carcinoma, proposing the ALKBH5-NEAT1 axis as a potential therapeutic target [27]. This evidence concerns the gene NEAT1 and colorectal carcinoma.